- Previous Close
4,195.00 - Open
4,180.00 - Bid 4,188.00 x --
- Ask 4,205.00 x --
- Day's Range
4,143.00 - 4,225.00 - 52 Week Range
3,316.00 - 5,138.00 - Volume
332,800 - Avg. Volume
359,244 - Market Cap (intraday)
319.042B - Beta (5Y Monthly) 0.07
- PE Ratio (TTM)
11.76 - EPS (TTM)
357.09 - Earnings Date May 9, 2025 - May 19, 2025
- Forward Dividend & Yield 136.00 (3.24%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
5,426.00
Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, and urinary problems. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.
www.tsumura.co.jp4,138
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: 4540.T
View MorePerformance Overview: 4540.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4540.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4540.T
View MoreValuation Measures
Market Cap
319.04B
Enterprise Value
316.35B
Trailing P/E
11.76
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.86
Price/Book (mrq)
1.09
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
6.27
Financial Highlights
Profitability and Income Statement
Profit Margin
15.79%
Return on Assets (ttm)
4.71%
Return on Equity (ttm)
9.25%
Revenue (ttm)
171.79B
Net Income Avi to Common (ttm)
27.12B
Diluted EPS (ttm)
357.09
Balance Sheet and Cash Flow
Total Cash (mrq)
83.05B
Total Debt/Equity (mrq)
25.25%
Levered Free Cash Flow (ttm)
9.14B